Article thumbnail
Location of Repository

Enhanced responsiveness of Ghsr Q343X rats to ghrelin results in enhanced adiposity without increased appetite

By Yacine Chebani, Candice Marion, Philippe Zizzari, Khadidja Chettab, Marie Pastor, Marie Korostelev, David Geny, Jacques Epelbaum, Virginie Tolle, Séverine Morisset-Lopez and Jacques Pantel

Abstract

International audienceThe ability of the gut hormone ghrelin to promote positive energy balance is mediated by the growth hormone secretagogue receptor (GHSR). GHSR is a G protein-coupled receptor (GPCR) that is found centrally and peripherally and that can signal in a ligand-independent manner basally or when heterodimerized with other GPCRs. However, current Ghsr knockout models cannot dissect ghrelin-dependent and –independent signaling, precluding assessment of the physiological importance of these signaling pathways. An animal model carrying a Ghsr mutation that preserves GHSR cell surface abundance, but selectively alters GHSR signaling, would be a useful tool to decipher GHSR signaling in vivo. We used rats with the GhsrQ343X mutation (GhsrM/M), which is predicted to delete the distal part of the GHSR C-terminus tail, a domain critical for the signal termination processes of receptor internalization and beta-arrestin recruitment. In cells, the Q343X GHSR mutant showed enhanced ligand-induced G protein-dependent signaling and blunted activity of processes involved in GPCR signal termination. GhsrM/M rats displayed enhanced responses to submaximal doses of ghrelin or GHSR agonist. Moreover, GhsrM/M rats had a more stable body weight under caloric restriction, a condition that increases endogenous ghrelin tone, whereas under standard housing conditions, GhsrM/M rats showed increased body weight, adiposity and reduced glucose tolerance. Overall, our data stresses the physiological role of the distal domain of GHSR C-terminus as a suppressor of ghrelin sensitivity and we propose using the GhsrM/M rat as a physiological model of gain-of-function in Ghsr to identify treatments for obesity-related conditions

Topics: Obesity, Ghrelin/physiology, Arrestin, Ghrelin receptor, Mutation Analysis, G protein coupled receptor GPCR, Phosphorylation sites, Food intake, [SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism, [SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences
Publisher: American Association for the Advancement of Science
Year: 2016
DOI identifier: 10.1126/scisignal.aae0374
OAI identifier: oai:HAL:inserm-01463897v1
Provided by: HAL-Inserm
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://www.hal.inserm.fr/inse... (external link)
  • https://www.hal.inserm.fr/inse... (external link)
  • https://www.hal.inserm.fr/inse... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.